Publication | Closed Access
Rationally designed hecogenin thiosemicarbazone analogs as novel MEK inhibitors for the control of breast malignancies
25
Citations
30
References
2017
Year
MedicineHecogenin Thiosemicarbazone AnalogsNovel Mek InhibitorsBreast CancerPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyNovel TherapyTumor BiologyDrug DiscoveryBreast Malignancies
| Year | Citations | |
|---|---|---|
Page 1
Page 1